Page last updated: 2024-10-23

benzo(a)pyrene and Breast Neoplasms

benzo(a)pyrene has been researched along with Breast Neoplasms in 91 studies

Benzo(a)pyrene: A potent mutagen and carcinogen. It is a public health concern because of its possible effects on industrial workers, as an environmental pollutant, an as a component of tobacco smoke.
benzo[a]pyrene : An ortho- and peri-fused polycyclic arene consisting of five fused benzene rings.

Breast Neoplasms: Tumors or cancer of the human BREAST.

Research Excerpts

ExcerptRelevanceReference
"A naturally occurring, cocoa-derived pentameric procyanidin (pentamer) was previously shown to cause G0/G1 cell cycle arrest in human breast cancer cells by an unknown molecular mechanism."7.73Pentameric procyanidin from Theobroma cacao selectively inhibits growth of human breast cancer cells. ( Dickson, RB; Galperin, M; Knezevic, V; Metheny-Barlow, LJ; Ramesh, A; Ramljak, D; Romanczyk, LJ; Thompson, N, 2005)
"In T-47D breast cancer cells, exposure to 0."5.35Induction of CYP1A1 and CYP1B1 by benzo(k)fluoranthene and benzo(a)pyrene in T-47D human breast cancer cells: roles of PAH interactions and PAH metabolites. ( Hussain, MM; Kaminsky, LS; Pentecost, BT; Spink, BC; Spink, DC; Vakharia, DD; Wu, SJ, 2008)
"Findings will provide timely information on the safety, efficacy, and optimal dosing of t-PA to treat moderate/severe COVID-19-induced ARDS, which can be rapidly adapted to a phase III trial (NCT04357730; FDA IND 149634)."4.21 ( Abbasi, S; Abd El-Wahab, A; Abdallah, M; Abebe, G; Aca-Aca, G; Adama, S; Adefegha, SA; Adidigue-Ndiome, R; Adiseshaiah, P; Adrario, E; Aghajanian, C; Agnese, W; Ahmad, A; Ahmad, I; Ahmed, MFE; Akcay, OF; Akinmoladun, AC; Akutagawa, T; Alakavuklar, MA; Álava-Rabasa, S; Albaladejo-Florín, MJ; Alexandra, AJE; Alfawares, R; Alferiev, IS; Alghamdi, HS; Ali, I; Allard, B; Allen, JD; Almada, E; Alobaid, A; Alonso, GL; Alqahtani, YS; Alqarawi, W; Alsaleh, H; Alyami, BA; Amaral, BPD; Amaro, JT; Amin, SAW; Amodio, E; Amoo, ZA; Andia Biraro, I; Angiolella, L; Anheyer, D; Anlay, DZ; Annex, BH; Antonio-Aguirre, B; Apple, S; Arbuznikov, AV; Arinsoy, T; Armstrong, DK; Ash, S; Aslam, M; Asrie, F; Astur, DC; Atzrodt, J; Au, DW; Aucoin, M; Auerbach, EJ; Azarian, S; Ba, D; Bai, Z; Baisch, PRM; Balkissou, AD; Baltzopoulos, V; Banaszewski, M; Banerjee, S; Bao, Y; Baradwan, A; Barandika, JF; Barger, PM; Barion, MRL; Barrett, CD; Basudan, AM; Baur, LE; Baz-Rodríguez, SA; Beamer, P; Beaulant, A; Becker, DF; Beckers, C; Bedel, J; Bedlack, R; Bermúdez de Castro, JM; Berry, JD; Berthier, C; Bhattacharya, D; Biadgo, B; Bianco, G; Bianco, M; Bibi, S; Bigliardi, AP; Billheimer, D; Birnie, DH; Biswas, K; Blair, HC; Bognetti, P; Bolan, PJ; Bolla, JR; Bolze, A; Bonnaillie, P; Borlimi, R; Bórquez, J; Bottari, NB; Boulleys-Nana, JR; Brighetti, G; Brodeur, GM; Budnyak, T; Budnyk, S; Bukirwa, VD; Bulman, DM; Burm, R; Busman-Sahay, K; Butcher, TW; Cai, C; Cai, H; Cai, L; Cairati, M; Calvano, CD; Camacho-Ordóñez, A; Camela, E; Cameron, T; Campbell, BS; Cansian, RL; Cao, Y; Caporale, AS; Carciofi, AC; Cardozo, V; Carè, J; Carlos, AF; Carozza, R; Carroll, CJW; Carsetti, A; Carubelli, V; Casarotta, E; Casas, M; Caselli, G; Castillo-Lora, J; Cataldi, TRI; Cavalcante, ELB; Cavaleiro, A; Cayci, Z; Cebrián-Tarancón, C; Cedrone, E; Cella, D; Cereda, C; Ceretti, A; Ceroni, M; Cha, YH; Chai, X; Chang, EF; Chang, TS; Chanteux, H; Chao, M; Chaplin, BP; Chaturvedi, S; Chaturvedi, V; Chaudhary, DK; Chen, A; Chen, C; Chen, HY; Chen, J; Chen, JJ; Chen, K; Chen, L; Chen, Q; Chen, R; Chen, SY; Chen, TY; Chen, WM; Chen, X; Chen, Y; Cheng, G; Cheng, GJ; Cheng, J; Cheng, YH; Cheon, HG; Chew, KW; Chhoker, S; Chiu, WN; Choi, ES; Choi, MJ; Choi, SD; Chokshi, S; Chorny, M; Chu, KI; Chu, WJ; Church, AL; Cirrincione, A; Clamp, AR; Cleff, MB; Cohen, M; Coleman, RL; Collins, SL; Colombo, N; Conduit, N; Cong, WL; Connelly, MA; Connor, J; Cooley, K; Correa Ramos Leal, I; Cose, S; Costantino, C; Cottrell, M; Cui, L; Cundall, J; Cutaia, C; Cutler, CW; Cuypers, ML; da Silva Júnior, FMR; Dahal, RH; Damiani, E; Damtie, D; Dan-Li, W; Dang, Z; Dasa, SSK; Davin, A; Davis, DR; de Andrade, CM; de Jong, PL; de Oliveira, D; de Paula Dorigam, JC; Dean, A; Deepa, M; Delatour, C; Dell'Aiera, S; Delley, MF; den Boer, RB; Deng, L; Deng, Q; Depner, RM; Derdau, V; Derici, U; DeSantis, AJ; Desmarini, D; Diffo-Sonkoue, L; Divizia, M; Djenabou, A; Djordjevic, JT; Dobrovolskaia, MA; Domizi, R; Donati, A; Dong, Y; Dos Santos, M; Dos Santos, MP; Douglas, RG; Duarte, PF; Dullaart, RPF; Duscha, BD; Edwards, LA; Edwards, TE; Eichenwald, EC; El-Baba, TJ; Elashiry, M; Elashiry, MM; Elashry, SH; Elliott, A; Elsayed, R; Emerson, MS; Emmanuel, YO; Emory, TH; Endale-Mangamba, LM; Enten, GA; Estefanía-Fernández, K; Estes, JD; Estrada-Mena, FJ; Evans, S; Ezra, L; Faria de, RO; Farraj, AK; Favre, C; Feng, B; Feng, J; Feng, L; Feng, W; Feng, X; Feng, Z; Fernandes, CLF; Fernández-Cuadros, ME; Fernie, AR; Ferrari, D; Florindo, PR; Fong, PC; Fontes, EPB; Fontinha, D; Fornari, VJ; Fox, NP; Fu, Q; Fujitaka, Y; Fukuhara, K; Fumeaux, T; Fuqua, C; Fustinoni, S; Gabbanelli, V; Gaikwad, S; Gall, ET; Galli, A; Gancedo, MA; Gandhi, MM; Gao, D; Gao, K; Gao, M; Gao, Q; Gao, X; Gao, Y; Gaponenko, V; Garber, A; Garcia, EM; García-Campos, C; García-Donas, J; García-Pérez, AL; Gasparri, F; Ge, C; Ge, D; Ge, JB; Ge, X; George, I; George, LA; Germani, G; Ghassemi Tabrizi, S; Gibon, Y; Gillent, E; Gillies, RS; Gilmour, MI; Goble, S; Goh, JC; Goiri, F; Goldfinger, LE; Golian, M; Gómez, MA; Gonçalves, J; Góngora-García, OR; Gonul, I; González, MA; Govers, TM; Grant, PC; Gray, EH; Gray, JE; Green, MS; Greenwald, I; Gregory, MJ; Gretzke, D; Griffin-Nolan, RJ; Griffith, DC; Gruppen, EG; Guaita, A; Guan, P; Guan, X; Guerci, P; Guerrero, DT; Guo, M; Guo, P; Guo, R; Guo, X; Gupta, J; Guz, G; Hajizadeh, N; Hamada, H; Haman-Wabi, AB; Han, TT; Hannan, N; Hao, S; Harjola, VP; Harmon, M; Hartmann, MSM; Hartwig, JF; Hasani, M; Hawthorne, WJ; Haykal-Coates, N; Hazari, MS; He, DL; He, P; He, SG; Héau, C; Hebbar Kannur, K; Helvaci, O; Heuberger, DM; Hidalgo, F; Hilty, MP; Hirata, K; Hirsch, A; Hoffman, AM; Hoffmann, JF; Holloway, RW; Holmes, RK; Hong, S; Hongisto, M; Hopf, NB; Hörlein, R; Hoshino, N; Hou, Y; Hoven, NF; Hsieh, YY; Hsu, CT; Hu, CW; Hu, JH; Hu, MY; Hu, Y; Hu, Z; Huang, C; Huang, D; Huang, DQ; Huang, L; Huang, Q; Huang, R; Huang, S; Huang, SC; Huang, W; Huang, Y; Huffman, KM; Hung, CH; Hung, CT; Huurman, R; Hwang, SM; Hyun, S; Ibrahim, AM; Iddi-Faical, A; Immordino, P; Isla, MI; Jacquemond, V; Jacques, T; Jankowska, E; Jansen, JA; Jäntti, T; Jaque-Fernandez, F; Jarvis, GA; Jatt, LP; Jeon, JW; Jeong, SH; Jhunjhunwala, R; Ji, F; Jia, X; Jia, Y; Jian-Bo, Z; Jiang, GD; Jiang, L; Jiang, W; Jiang, WD; Jiang, Z; Jiménez-Hoyos, CA; Jin, S; Jobling, MG; John, CM; John, T; Johnson, CB; Jones, KI; Jones, WS; Joseph, OO; Ju, C; Judeinstein, P; Junges, A; Junnarkar, M; Jurkko, R; Kaleka, CC; Kamath, AV; Kang, X; Kantsadi, AL; Kapoor, M; Karim, Z; Kashuba, ADM; Kassa, E; Kasztura, M; Kataja, A; Katoh, T; Kaufman, JS; Kaupp, M; Kehinde, O; Kehrenberg, C; Kemper, N; Kerr, CW; Khan, AU; Khan, MF; Khan, ZUH; Khojasteh, SC; Kilburn, S; Kim, CG; Kim, DU; Kim, DY; Kim, HJ; Kim, J; Kim, OH; Kim, YH; King, C; Klein, A; Klingler, L; Knapp, AK; Ko, TK; Kodavanti, UP; Kolla, V; Kong, L; Kong, RY; Kong, X; Kore, S; Kortz, U; Korucu, B; Kovacs, A; Krahnert, I; Kraus, WE; Kuang, SY; Kuehn-Hajder, JE; Kurz, M; Kuśtrowski, P; Kwak, YD; Kyttaris, VC; Laga, SM; Laguerre, A; Laloo, A; Langaro, MC; Langham, MC; Lao, X; Larocca, MC; Lassus, J; Lattimer, TA; Lazar, S; Le, MH; Leal, DB; Leal, M; Leary, A; Ledermann, JA; Lee, JF; Lee, MV; Lee, NH; Leeds, CM; Leeds, JS; Lefrandt, JD; Leicht, AS; Leonard, M; Lev, S; Levy, K; Li, B; Li, C; Li, CM; Li, DH; Li, H; Li, J; Li, L; Li, LJ; Li, N; Li, P; Li, T; Li, X; Li, XH; Li, XQ; Li, XX; Li, Y; Li, Z; Li, ZY; Liao, YF; Lin, CC; Lin, MH; Lin, Y; Ling, Y; Links, TP; Lira-Romero, E; Liu, C; Liu, D; Liu, H; Liu, J; Liu, L; Liu, LP; Liu, M; Liu, T; Liu, W; Liu, X; Liu, XH; Liu, Y; Liuwantara, D; Ljumanovic, N; Lobo, L; Lokhande, K; Lopes, A; Lopes, RMRM; López-Gutiérrez, JC; López-Muñoz, MJ; López-Santamaría, M; Lorenzo, C; Lorusso, D; Losito, I; Lu, C; Lu, H; Lu, HZ; Lu, SH; Lu, SN; Lu, Y; Lu, ZY; Luboga, F; Luo, JJ; Luo, KL; Luo, Y; Lutomski, CA; Lv, W; M Piedade, MF; Ma, J; Ma, JQ; Ma, JX; Ma, N; Ma, P; Ma, S; Maciel, M; Madureira, M; Maganaris, C; Maginn, EJ; Mahnashi, MH; Maierhofer, M; Majetschak, M; Malla, TR; Maloney, L; Mann, DL; Mansuri, A; Marelli, E; Margulis, CJ; Marrella, A; Martin, BL; Martín-Francés, L; Martínez de Pinillos, M; Martínez-Navarro, EM; Martinez-Quintanilla Jimenez, D; Martínez-Velasco, A; Martínez-Villaseñor, L; Martinón-Torres, M; Martins, BA; Massongo, M; Mathew, AP; Mathews, D; Matsui, J; Matsumoto, KI; Mau, T; Maves, RC; Mayclin, SJ; Mayer, JM; Maynard, ND; Mayr, T; Mboowa, MG; McEvoy, MP; McIntyre, RC; McKay, JA; McPhail, MJW; McVeigh, AL; Mebazaa, A; Medici, V; Medina, DN; Mehmood, T; Mei-Li, C; Melku, M; Meloncelli, S; Mendes, GC; Mendoza-Velásquez, C; Mercadante, R; Mercado, MI; Merenda, MEZ; Meunier, J; Mi, SL; Michels, M; Mijatovic, V; Mikhailov, V; Milheiro, SA; Miller, DC; Ming, F; Mitsuishi, M; Miyashita, T; Mo, J; Mo, S; Modesto-Mata, M; Moeller, S; Monte, A; Monteiro, L; Montomoli, J; Moore, EE; Moore, HB; Moore, PK; Mor, MK; Moratalla-López, N; Moratilla Lapeña, L; Moreira, R; Moreno, MA; Mörk, AC; Morton, M; Mosier, JM; Mou, LH; Mougharbel, AS; Muccillo-Baisch, AL; Muñoz-Serrano, AJ; Mustafa, B; Nair, GM; Nakanishi, I; Nakanjako, D; Naraparaju, K; Nawani, N; Neffati, R; Neil, EC; Neilipovitz, D; Neira-Borrajo, I; Nelson, MT; Nery, PB; Nese, M; Nguyen, F; Nguyen, MH; Niazy, AA; Nicolaï, J; Nogueira, F; Norbäck, D; Novaretti, JV; O'Donnell, T; O'Dowd, A; O'Malley, DM; Oaknin, A; Ogata, K; Ohkubo, K; Ojha, M; Olaleye, MT; Olawande, B; Olomo, EJ; Ong, EWY; Ono, A; Onwumere, J; Ortiz Bibriesca, DM; Ou, X; Oza, AM; Ozturk, K; Özütemiz, C; Palacio-Pastrana, C; Palaparthi, A; Palevsky, PM; Pan, K; Pantanetti, S; Papachristou, DJ; Pariani, A; Parikh, CR; Parissis, J; Paroul, N; Parry, S; Patel, N; Patel, SM; Patel, VC; Pawar, S; Pefura-Yone, EW; Peixoto Andrade, BCO; Pelepenko, LE; Peña-Lora, D; Peng, S; Pérez-Moro, OS; Perez-Ortiz, AC; Perry, LM; Peter, CM; Phillips, NJ; Phillips, P; Pia Tek, J; Piner, LW; Pinto, EA; Pinto, SN; Piyachaturawat, P; Poka-Mayap, V; Polledri, E; Poloni, TE; Ponessa, G; Poole, ST; Post, AK; Potter, TM; Pressly, BB; Prouty, MG; Prudêncio, M; Pulkki, K; Pupier, C; Qian, H; Qian, ZP; Qiu, Y; Qu, G; Rahimi, S; Rahman, AU; Ramadan, H; Ramanna, S; Ramirez, I; Randolph, GJ; Rasheed, A; Rault, J; Raviprakash, V; Reale, E; Redpath, C; Rema, V; Remucal, CK; Remy, D; Ren, T; Ribeiro, LB; Riboli, G; Richards, J; Rieger, V; Rieusset, J; Riva, A; Rivabella Maknis, T; Robbins, JL; Robinson, CV; Roche-Campo, F; Rodriguez, R; Rodríguez-de-Cía, J; Rollenhagen, JE; Rosen, EP; Rub, D; Rubin, N; Rubin, NT; Ruurda, JP; Saad, O; Sabell, T; Saber, SE; Sabet, M; Sadek, MM; Saejio, A; Salinas, RM; Saliu, IO; Sande, D; Sang, D; Sangenito, LS; Santos, ALSD; Sarmiento Caldas, MC; Sassaroli, S; Sassi, V; Sato, J; Sauaia, A; Saunders, K; Saunders, PR; Savarino, SJ; Scambia, G; Scanlon, N; Schetinger, MR; Schinkel, AFL; Schladweiler, MC; Schofield, CJ; Schuepbach, RA; Schulz, J; Schwartz, N; Scorcella, C; Seeley, J; Seemann, F; Seinige, D; Sengoku, T; Seravalli, J; Sgromo, B; Shaheen, MY; Shan, L; Shanmugam, S; Shao, H; Sharma, S; Shaw, KJ; Shen, BQ; Shen, CH; Shen, P; Shen, S; Shen, Y; Shen, Z; Shi, J; Shi-Li, L; Shimoda, K; Shoji, Y; Shun, C; Silva, MA; Silva-Cardoso, J; Simas, NK; Simirgiotis, MJ; Sincock, SA; Singh, MP; Sionis, A; Siu, J; Sivieri, EM; Sjerps, MJ; Skoczen, SL; Slabon, A; Slette, IJ; Smith, MD; Smith, S; Smith, TG; Snapp, KS; Snow, SJ; Soares, MCF; Soberman, D; Solares, MD; Soliman, I; Song, J; Sorooshian, A; Sorrell, TC; Spinar, J; Staudt, A; Steinhart, C; Stern, ST; Stevens, DM; Stiers, KM; Stimming, U; Su, YG; Subbian, V; Suga, H; Sukhija-Cohen, A; Suksamrarn, A; Suksen, K; Sun, J; Sun, M; Sun, P; Sun, W; Sun, XF; Sun, Y; Sundell, J; Susan, LF; Sutjarit, N; Swamy, KV; Swisher, EM; Sykes, C; Takahashi, JA; Talmor, DS; Tan, B; Tan, ZK; Tang, L; Tang, S; Tanner, JJ; Tanwar, M; Tarazi, Z; Tarvasmäki, T; Tay, FR; Teketel, A; Temitayo, GI; Thersleff, T; Thiessen Philbrook, H; Thompson, LC; Thongon, N; Tian, B; Tian, F; Tian, Q; Timothy, AT; Tingle, MD; Titze, IR; Tolppanen, H; Tong, W; Toyoda, H; Tronconi, L; Tseng, CH; Tu, H; Tu, YJ; Tung, SY; Turpault, S; Tuynman, JB; Uemoto, AT; Ugurlu, M; Ullah, S; Underwood, RS; Ungell, AL; Usandizaga-Elio, I; Vakonakis, I; van Boxel, GI; van den Beucken, JJJP; van der Boom, T; van Slegtenhorst, MA; Vanni, JR; Vaquera, A; Vasconcellos, RS; Velayos, M; Vena, R; Ventura, G; Verso, MG; Vincent, RP; Vitale, F; Vitali, S; Vlek, SL; Vleugels, MPH; Volkmann, N; Vukelic, M; Wagner Mackenzie, B; Wairagala, P; Waller, SB; Wan, J; Wan, MT; Wan, Y; Wang, CC; Wang, H; Wang, J; Wang, JF; Wang, K; Wang, L; Wang, M; Wang, S; Wang, WM; Wang, X; Wang, Y; Wang, YD; Wang, YF; Wang, Z; Wang, ZG; Warriner, K; Weberpals, JI; Weerachayaphorn, J; Wehrli, FW; Wei, J; Wei, KL; Weinheimer, CJ; Weisbord, SD; Wen, S; Wendel Garcia, PD; Williams, JW; Williams, R; Winkler, C; Wirman, AP; Wong, S; Woods, CM; Wu, B; Wu, C; Wu, F; Wu, P; Wu, S; Wu, Y; Wu, YN; Wu, ZH; Wurtzel, JGT; Xia, L; Xia, Z; Xia, ZZ; Xiao, H; Xie, C; Xin, ZM; Xing, Y; Xing, Z; Xu, S; Xu, SB; Xu, T; Xu, X; Xu, Y; Xue, L; Xun, J; Yaffe, MB; Yalew, A; Yamamoto, S; Yan, D; Yan, H; Yan, S; Yan, X; Yang, AD; Yang, E; Yang, H; Yang, J; Yang, JL; Yang, K; Yang, M; Yang, P; Yang, Q; Yang, S; Yang, W; Yang, X; Yang, Y; Yao, JC; Yao, WL; Yao, Y; Yaqub, TB; Ye, J; Ye, W; Yen, CW; Yeter, HH; Yin, C; Yip, V; Yong-Yi, J; Yu, HJ; Yu, MF; Yu, S; Yu, W; Yu, WW; Yu, X; Yuan, P; Yuan, Q; Yue, XY; Zaia, AA; Zakhary, SY; Zalwango, F; Zamalloa, A; Zamparo, P; Zampini, IC; Zani, JL; Zeitoun, R; Zeng, N; Zenteno, JC; Zepeda-Palacio, C; Zhai, C; Zhang, B; Zhang, G; Zhang, J; Zhang, K; Zhang, Q; Zhang, R; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, B; Zhao, D; Zhao, G; Zhao, H; Zhao, Q; Zhao, R; Zhao, S; Zhao, T; Zhao, X; Zhao, XA; Zhao, Y; Zhao, Z; Zheng, Z; Zhi-Min, G; Zhou, CL; Zhou, HD; Zhou, J; Zhou, W; Zhou, XQ; Zhou, Z; Zhu, C; Zhu, H; Zhu, L; Zhu, Y; Zitzmann, N; Zou, L; Zou, Y, 2022)
"Reports of the ability of estrogenic agents such as 17beta-estradiol (E2), estriol (E3) and bisphenol A (BPA) to induce micronuclei (MN) in MCF-7 breast cancer cells have prompted us to investigate whether these effects are linked to activation of the estrogen receptor (ER) alpha."3.74Estrogens and genomic instability in human breast cancer cells--involvement of Src/Raf/Erk signaling in micronucleus formation by estrogenic chemicals. ( Kabil, A; Kortenkamp, A; Silva, E, 2008)
"A naturally occurring, cocoa-derived pentameric procyanidin (pentamer) was previously shown to cause G0/G1 cell cycle arrest in human breast cancer cells by an unknown molecular mechanism."3.73Pentameric procyanidin from Theobroma cacao selectively inhibits growth of human breast cancer cells. ( Dickson, RB; Galperin, M; Knezevic, V; Metheny-Barlow, LJ; Ramesh, A; Ramljak, D; Romanczyk, LJ; Thompson, N, 2005)
"Breast cancer is the most common malignant tumor in women worldwide, and environmental pollutants are considered to be risk factors."1.91Whole transcriptome sequencing and competitive endogenous RNA regulation network construction analysis in benzo[a]pyrene-treated breast cancer cells. ( Lao, QF; Li, SL; Liu, L; Martin, FL; Pang, WY; Qiao, ZP; Zhang, QQ, 2023)
"Women with primary breast cancer were identified using the Danish Cancer Registry and they were required to have information on either maternal or paternal employment history, which resulted in the inclusion of 5587 cases."1.91Parental occupational exposure to chemicals and risk of breast cancer in female offspring. ( Hansen, J; Pedersen, JE, 2023)
"Breast cancer is the most commonly diagnosed malignancy in females, the etiology being multifactorial and includes the role of lifestyle exposure to DNA-damaging chemicals such as dietary carcinogens benzo (a) pyrene (BaP) and 2-amino-1-methyl-6-phenylimidazo [4, 5-b] pyridine (PhIP)."1.51Interleukin-6 selectively induces drug metabolism to potentiate the genotoxicity of dietary carcinogens in mammary cells. ( David, RM; Gooderham, NJ; Malik, DE, 2019)
"Metastasis is the leading cause of deaths in patients with breast cancer."1.42Effects of exposure to benzo[a]pyrene on metastasis of breast cancer are mediated through ROS-ERK-MMP9 axis signaling. ( Dai, C; Guo, J; Ji, W; Song, L; Xu, Y; Zhan, L, 2015)
"Initiation of carcinogenesis was measured by transient endpoints induced in a single exposure, while progression of carcinogenesis was measured by acquisition of constitutive endpoints in cumulative exposures."1.40Chronic exposure to combined carcinogens enhances breast cell carcinogenesis with mesenchymal and stem-like cell properties. ( Pluchino, LA; Wang, HC, 2014)
"More than 85% breast cancers are sporadic and attributable to long-term exposure to environmental carcinogens through a multistep and multiyear disease process."1.40Dipyridamole intervention of breast cell carcinogenesis. ( Choudhary, S; Sood, S; Wang, HC, 2014)
"Sporadic breast cancers are mainly attributable to long-term exposure to environmental factors, via a multi-year, multi-step, and multi-path process of tumorigenesis involving cumulative genetic and epigenetic alterations in the chronic carcinogenesis of breast cells from a non-cancerous stage to precancerous and cancerous stages."1.38Green tea catechin extract in intervention of chronic breast cell carcinogenesis induced by environmental carcinogens. ( Rathore, K; Wang, HC, 2012)
"Alcohol drinking was also directly associated with breast cancer risk (OR 1."1.37Dietary benzo[a]pyrene, alcohol drinking, and risk of breast cancer: a case-control study in Uruguay. ( Acosta, G; Boffetta, P; Correa, P; De Stefani, E; Deneo-Pellegrini, H; Mendilaharsu, M; Ronco, AL, 2011)
"Breast cancer is the most common type of cancer among women in northern America and northern Europe; dietary prevention is a cost-efficient strategy to reduce the risk of this disease."1.36Grape seed proanthocyanidin suppression of breast cell carcinogenesis induced by chronic exposure to combined 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and benzo[a]pyrene. ( Lin, D; Rathore, K; Siriwardhana, N; Song, X; Wang, HC, 2010)
"In T-47D breast cancer cells, exposure to 0."1.35Induction of CYP1A1 and CYP1B1 by benzo(k)fluoranthene and benzo(a)pyrene in T-47D human breast cancer cells: roles of PAH interactions and PAH metabolites. ( Hussain, MM; Kaminsky, LS; Pentecost, BT; Spink, BC; Spink, DC; Vakharia, DD; Wu, SJ, 2008)
"In addition, invasive breast cancer cells have been reported to over express COX-II and PGE(2)."1.33Benzo-[a]-pyrene increases invasion in MDA-MB-231 breast cancer cells via increased COX-II expression and prostaglandin E2 (PGE2) output. ( Foster, WG; Holloway, AC; Miller, ME, 2005)
"This in vitro cancer model can be used as a valuable model in the study of breast carcinogenesis."1.33Oncoprotein expression and morphological phenotypes of human breast epithelial cells transformed by the c-Ha-ras oncogene. ( Alvarado, ME; Calaf, GM; Hei, TK, 2005)
"In MCF-7, the ER-positive human breast cancer cell line, treated with BaP, the formation of BaP-DNA adducts and DNA synthesis were inhibited in a concentration-responsive manner, but there was no change in MDA-MB-231, the ER-negative cell line."1.33Effect of estrogen receptor (ER) on benzo[a]pyrene-DNA adduct formation in human breast cancer cells. ( Kang, SC; Lee, BM, 2005)
"In sporadic breast cancers, BRCA-1 expression is down-regulated in the absence of mutations in the BRCA-1 gene."1.33The ligand status of the aromatic hydrocarbon receptor modulates transcriptional activation of BRCA-1 promoter by estrogen. ( Hockings, JK; Kemp, MQ; Morgan, SS; Romagnolo, DF; Selmin, O; Thorne, PA, 2006)
"We evaluated XRCC1 gene expression in breast cancer cell lines and carcinogen-induced apoptosis in benign breast epithelial cells in relation to XRCC1 genotypes."1.33An intronic polymorphism associated with increased XRCC1 expression, reduced apoptosis and familial breast cancer. ( Bu, D; Euhus, DM; Kildebeck, E; Lewis, CM; Tomlinson, G; Zhang, C, 2006)
"PBMC from breast cancer patients showed higher levels of residual DNA double strand breaks 30 min after exposure to radiation than PBMC from patients with benign breast disease (1."1.33Carcinogen-induced DNA double strand break repair in sporadic breast cancer. ( Euhus, D; Naftalis, E; Zhang, C, 2006)
"In this work, the human breast carcinoma cell line, MCF-7, was used as the model system to perform BaP measurements in single cells."1.31Nanosensor for in vivo measurement of the carcinogen benzo[a]pyrene in a single cell. ( Cullum, BM; Griffin, GD; Kasili, PM; Vo-Dinh, T, 2002)
"These observations suggest that genetic susceptibility to carcinogen exposure may play an important role in breast carcinogenesis."1.31Genetic and environmental determinants on tissue response to in vitro carcinogen exposure and risk of breast cancer. ( Bondy, ML; Chang, P; Li, D; Petrulis, E; Sahin, AA; Singletary, SE; Walcott, FL; Zhang, W; Zhu, J, 2002)
"A human breast cancer cell line, MCF-7, transiently transfected with a chimeric estrogen receptor (Gal4-HEG0) and a luciferase reporter plasmid (17m5-G-Luc), was used to investigate the estrogenic activity of benzo[a]pyrene (B[a]P), a prototypical polyaromatic hydrocarbon (PAH)."1.31Activity of benzo[a]pyrene and its hydroxylated metabolites in an estrogen receptor-alpha reporter gene assay. ( Bartels, MJ; Carney, EW; Charles, GD; Freshour, NL; Gollapudi, BB; Zacharewski, TR, 2000)
" The aim of this study was to examine the bioavailability of these compounds to human breast tissue and their ability to bind to DNA to form DNA adducts."1.31Analysis of DNA adducts by accelerator mass spectrometry in human breast tissue after administration of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and benzo[a]pyrene. ( Coxhead, JM; Cupid, BC; Garner, RC; Lightfoot, TJ; Nicholson, S, 2000)
"The phenotypic changes of breast cancer progression were studied through the use of scanning and transmission electron microscopy."1.31Morphological phenotypes in neoplastic progression of benz(alpha)pyrene-treated breast epithelial cells. ( Alvarado, ME; Calaf, G; Russo, J, 2000)
" A clear dose-response effect on formation of DNA adducts was obtained for B[a]P and a Standard Reference Material (SRM) of diesel particulate matter."1.31Time- and dose-dependent DNA binding of PAHs derived from diesel particle extracts, benzo[a]pyrene and 5-methychrysene in a human mammary carcinoma cell line (MCF-7). ( Isotalo, S; Kuljukka-Rabb, T; Mikkonen, S; Peltonen, K; Rantanen, L; Savela, K, 2001)
"Wild-type MCF-7 human breast cancer cells were cultured for 3 months in 1 microM benzo[a]pyrene (BaP), and resistant clones were screened for inducibility of CYP1A1 gene expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)."1.29Benzo[a]pyrene-resistant MCF-7 human breast cancer cells. A unique aryl hydrocarbon-nonresponsive clone. ( Barhoumi, R; Burghardt, R; Craig, A; Gerlach, JH; Lu, YF; Moore, M; Safe, S; Wang, X; Wormke, M, 1994)
"The etiology of the majority of human breast cancers is unknown."1.29Aromatic DNA adducts in adjacent tissues of breast cancer patients: clues to breast cancer etiology. ( Dhingra, K; Hittelman, WN; Li, D; Wang, M, 1996)
"T47D human breast cancer cells were grown in 1 microM benzo[a]pyrene (BaP) for 3."1.29Isolation and characterization of variant benzo[a]pyrene-resistant T47D human breast-cancer cells. ( Moore, M; Ruh, M; Safe, S; Steinberg, M, 1996)
"The etiology of the majority of human breast cancers is unknown; however, oxidative stress and lipid peroxidation have been suggested to play a role in breast carcinogenesis."1.29Lipid peroxidation-induced putative malondialdehyde-DNA adducts in human breast tissues. ( de Andrade, M; Dhingra, K; Hittelman, WN; Li, D; Liehr, JG; Wang, M, 1996)
"MCF-7 human breast cancer cells, selected for resistance to adriamycin (AdrR), exhibit the phenotype of multidrug resistance (MDR)."1.27Altered regulation of P-450IA1 expression in a multidrug-resistant MCF-7 human breast cancer cell line. ( Averbuch, SD; Baird, WM; Cowan, KH; Fairchild, CR; Ivy, SP; Myers, CE; Nebert, DW; Tulpule, A, 1988)
"Thus, some human breast tumors had AHH activity exceeding that in rat liver."1.26Aryl hydrocarbon hydroxylase activity in mouse, rat, and human mammary tumors. ( Mason, ME; Okey, AB, 1981)

Research

Studies (91)

TimeframeStudies, this research(%)All Research%
pre-19908 (8.79)18.7374
1990's20 (21.98)18.2507
2000's42 (46.15)29.6817
2010's16 (17.58)24.3611
2020's5 (5.49)2.80

Authors

AuthorsStudies
Lao, QF3
Zhang, QQ3
Qiao, ZP3
Li, SL3
Liu, L5
Martin, FL6
Pang, WY3
Hong, S2
Song, JM1
Pedersen, JE1
Hansen, J1
Malik, DE2
David, RM2
Gooderham, NJ2
Nese, M1
Riboli, G1
Brighetti, G1
Sassi, V1
Camela, E1
Caselli, G1
Sassaroli, S1
Borlimi, R1
Aucoin, M1
Cooley, K1
Saunders, PR1
Carè, J1
Anheyer, D1
Medina, DN1
Cardozo, V1
Remy, D1
Hannan, N1
Garber, A1
Velayos, M1
Muñoz-Serrano, AJ1
Estefanía-Fernández, K1
Sarmiento Caldas, MC1
Moratilla Lapeña, L1
López-Santamaría, M1
López-Gutiérrez, JC1
Li, J1
Zhang, J1
Shen, S1
Zhang, B2
Yu, WW1
Toyoda, H1
Huang, DQ1
Le, MH1
Nguyen, MH1
Huang, R1
Zhu, L1
Wang, J6
Xue, L1
Yan, X2
Huang, S1
Li, Y6
Xu, T1
Li, C2
Ji, F1
Ming, F1
Zhao, Y2
Cheng, J1
Wang, Y3
Zhao, H1
Chen, K2
Zhao, XA1
Zou, L1
Sang, D1
Shao, H1
Guan, X1
Chen, X2
Chen, Y5
Wei, J1
Zhu, C1
Wu, C1
Moore, HB1
Barrett, CD1
Moore, EE1
Jhunjhunwala, R1
McIntyre, RC1
Moore, PK1
Hajizadeh, N1
Talmor, DS1
Sauaia, A1
Yaffe, MB1
Liu, C3
Lin, Y1
Dong, Y1
Wu, Y1
Bao, Y1
Yan, H2
Ma, J1
Fernández-Cuadros, ME1
Albaladejo-Florín, MJ1
Álava-Rabasa, S1
Usandizaga-Elio, I1
Martinez-Quintanilla Jimenez, D1
Peña-Lora, D1
Neira-Borrajo, I1
López-Muñoz, MJ1
Rodríguez-de-Cía, J1
Pérez-Moro, OS1
Abdallah, M1
Alsaleh, H1
Baradwan, A1
Alfawares, R1
Alobaid, A1
Rasheed, A1
Soliman, I1
Wendel Garcia, PD1
Fumeaux, T1
Guerci, P1
Heuberger, DM1
Montomoli, J2
Roche-Campo, F1
Schuepbach, RA1
Hilty, MP1
Poloni, TE1
Carlos, AF1
Cairati, M1
Cutaia, C1
Medici, V1
Marelli, E1
Ferrari, D1
Galli, A1
Bognetti, P1
Davin, A1
Cirrincione, A1
Ceretti, A1
Cereda, C1
Ceroni, M1
Tronconi, L1
Vitali, S1
Guaita, A1
Leeds, JS1
Raviprakash, V1
Jacques, T1
Scanlon, N1
Cundall, J1
Leeds, CM1
Riva, A1
Gray, EH1
Azarian, S1
Zamalloa, A1
McPhail, MJW1
Vincent, RP1
Williams, R1
Chokshi, S1
Patel, VC1
Edwards, LA1
Alqarawi, W1
Birnie, DH1
Golian, M1
Nair, GM1
Nery, PB1
Klein, A1
Davis, DR1
Sadek, MM1
Neilipovitz, D1
Johnson, CB1
Green, MS1
Redpath, C1
Miller, DC1
Beamer, P1
Billheimer, D1
Subbian, V1
Sorooshian, A1
Campbell, BS1
Mosier, JM1
Novaretti, JV1
Astur, DC1
Cavalcante, ELB1
Kaleka, CC1
Amaro, JT1
Cohen, M1
Huang, W1
Li, T1
Ling, Y1
Qian, ZP1
Zhang, YY1
Huang, D1
Xu, SB1
Liu, XH1
Xia, L1
Yang, Y3
Lu, SH1
Lu, HZ1
Zhang, R2
Ma, JX1
Tang, S1
Li, CM1
Wan, J1
Wang, JF1
Ma, JQ1
Luo, JJ1
Chen, HY2
Mi, SL1
Chen, SY1
Su, YG1
Ge, JB1
Milheiro, SA1
Gonçalves, J1
Lopes, RMRM1
Madureira, M1
Lobo, L1
Lopes, A1
Nogueira, F1
Fontinha, D1
Prudêncio, M1
M Piedade, MF1
Pinto, SN1
Florindo, PR1
Moreira, R1
Castillo-Lora, J1
Delley, MF1
Laga, SM1
Mayer, JM1
Sutjarit, N1
Thongon, N1
Weerachayaphorn, J1
Piyachaturawat, P1
Suksamrarn, A1
Suksen, K1
Papachristou, DJ1
Blair, HC1
Hu, Y1
Shen, P1
Zeng, N1
Wang, L3
Yan, D1
Cui, L1
Yang, K2
Zhai, C1
Yang, M1
Lao, X1
Sun, J1
Ma, N1
Wang, S1
Ye, W1
Guo, P1
Rahimi, S1
Singh, MP1
Gupta, J1
Nakanishi, I1
Ohkubo, K1
Shoji, Y1
Fujitaka, Y1
Shimoda, K1
Matsumoto, KI1
Fukuhara, K1
Hamada, H1
van der Boom, T1
Gruppen, EG1
Lefrandt, JD1
Connelly, MA1
Links, TP1
Dullaart, RPF1
Berry, JD1
Bedlack, R1
Mathews, D1
Agnese, W1
Apple, S1
Meloncelli, S1
Divizia, M1
Germani, G1
Adefegha, SA1
Bottari, NB1
Leal, DB1
de Andrade, CM1
Schetinger, MR1
Martínez-Velasco, A1
Perez-Ortiz, AC1
Antonio-Aguirre, B1
Martínez-Villaseñor, L1
Lira-Romero, E1
Palacio-Pastrana, C1
Zenteno, JC1
Ramirez, I1
Zepeda-Palacio, C1
Mendoza-Velásquez, C1
Camacho-Ordóñez, A1
Ortiz Bibriesca, DM1
Estrada-Mena, FJ1
Martin, BL1
Thompson, LC1
Kim, YH2
Snow, SJ1
Schladweiler, MC1
Phillips, P1
Harmon, M1
King, C1
Richards, J1
George, I1
Haykal-Coates, N1
Gilmour, MI1
Kodavanti, UP1
Hazari, MS1
Farraj, AK1
Shen, Z1
Zou, Y1
Gao, K1
Lazar, S1
Wurtzel, JGT1
Ma, P1
Goldfinger, LE1
Vukelic, M1
Laloo, A1
Kyttaris, VC1
Chen, R1
Chen, J2
Xun, J1
Hu, Z1
Huang, Q2
Steinhart, C1
Shen, Y1
Lu, H1
Mansuri, A1
Lokhande, K1
Kore, S1
Gaikwad, S1
Nawani, N1
Swamy, KV1
Junnarkar, M1
Pawar, S1
Shaheen, MY1
Basudan, AM1
Niazy, AA1
van den Beucken, JJJP1
Jansen, JA1
Alghamdi, HS1
Gao, Q2
Guo, X1
Cao, Y1
Jia, X1
Xu, S1
Lu, C2
Zhu, H2
Melku, M1
Abebe, G1
Teketel, A1
Asrie, F1
Yalew, A1
Biadgo, B1
Kassa, E1
Damtie, D1
Anlay, DZ1
Ahmed, MFE1
Ramadan, H1
Seinige, D1
Kehrenberg, C1
Abd El-Wahab, A1
Volkmann, N1
Kemper, N1
Schulz, J1
Hu, MY1
Wu, YN1
McEvoy, MP1
Wang, YF1
Cong, WL1
Liu, LP1
Li, XX1
Zhou, CL1
Chen, WM1
Wei, KL1
Tung, SY1
Shen, CH1
Chang, TS1
Yen, CW1
Hsieh, YY1
Chiu, WN1
Hu, JH1
Lu, SN1
Hung, CH1
Alakavuklar, MA1
Fuqua, C1
Luo, KL1
Underwood, RS1
Greenwald, I1
Elashiry, MM1
Elashiry, M1
Zeitoun, R1
Elsayed, R1
Tian, F1
Saber, SE1
Elashry, SH1
Tay, FR1
Cutler, CW1
O'Dowd, A1
Maciel, M1
Poole, ST1
Jobling, MG1
Rollenhagen, JE1
Woods, CM1
Sincock, SA1
McVeigh, AL1
Gregory, MJ1
Maves, RC1
Prouty, MG1
Holmes, RK1
Savarino, SJ1
Mor, MK1
Palevsky, PM1
Kaufman, JS1
Thiessen Philbrook, H1
Weisbord, SD1
Parikh, CR1
John, CM1
Phillips, NJ1
Jarvis, GA1
Zhu, Y1
Kilburn, S1
Kapoor, M1
Chaturvedi, S1
Shaw, KJ1
Chaturvedi, V1
Kong, X1
Zhang, T1
Xiao, H1
Feng, X1
Tu, H1
Feng, J1
Sabet, M1
Tarazi, Z1
Griffith, DC1
Nguyen, F1
Guan, P1
Guerrero, DT1
Kolla, V1
Naraparaju, K1
Perry, LM1
Soberman, D1
Pressly, BB1
Alferiev, IS1
Chorny, M1
Brodeur, GM1
Gao, X2
Cheng, YH1
Enten, GA1
DeSantis, AJ1
Gaponenko, V1
Majetschak, M1
Kim, DY1
Choi, MJ1
Ko, TK1
Lee, NH1
Kim, OH1
Cheon, HG1
Cai, H1
Yip, V1
Lee, MV1
Wong, S1
Saad, O1
Ma, S1
Ljumanovic, N1
Khojasteh, SC1
Kamath, AV1
Shen, BQ1
Cuypers, ML1
Chanteux, H1
Gillent, E1
Bonnaillie, P1
Saunders, K1
Beckers, C1
Delatour, C1
Dell'Aiera, S1
Ungell, AL1
Nicolaï, J1
Knapp, AK1
Chen, A1
Griffin-Nolan, RJ1
Baur, LE1
Carroll, CJW1
Gray, JE1
Hoffman, AM1
Li, X4
Post, AK1
Slette, IJ1
Collins, SL1
Luo, Y1
Smith, MD1
Temitayo, GI1
Olawande, B1
Emmanuel, YO1
Timothy, AT1
Kehinde, O1
Susan, LF1
Ezra, L1
Joseph, OO1
Lev, S1
Desmarini, D1
Liuwantara, D1
Sorrell, TC1
Hawthorne, WJ1
Djordjevic, JT1
Verso, MG1
Costantino, C1
Marrella, A1
Immordino, P1
Vitale, F1
Amodio, E1
Wang, YD1
Yao, WL1
Xin, ZM1
Han, TT1
Wang, ZG1
Chen, L1
Cai, C1
Zhang, Y4
Ba, D1
Wen, S1
Tian, Q1
Lv, W1
Cheng, G1
Li, N1
Yue, XY1
Chu, WJ1
Chen, Q1
Choi, ES1
Zhao, X3
Zhou, HD1
Sun, XF1
Sharma, S2
Chhoker, S1
Xie, C1
Ong, EWY1
Tan, ZK1
Evans, S1
Weinheimer, CJ1
Kovacs, A1
Williams, JW1
Randolph, GJ1
Jiang, W1
Barger, PM1
Mann, DL1
Liu, J2
Huang, Y1
Kong, L1
Yu, X1
Feng, B1
Liu, D1
Zhao, B1
Mendes, GC1
Yuan, P1
Ge, D1
Wang, WM1
Fontes, EPB1
Li, P1
Shan, L1
He, P1
Katoh, T1
Sengoku, T1
Hirata, K1
Ogata, K1
Suga, H1
Shun, C1
Yong-Yi, J1
Mei-Li, C1
Shi-Li, L1
Jian-Bo, Z1
Dan-Li, W1
Zhi-Min, G1
Ibrahim, AM1
Zakhary, SY1
Amin, SAW1
Ugurlu, M1
Fornari, VJ1
Hartmann, MSM1
Vanni, JR1
Rodriguez, R1
Langaro, MC1
Pelepenko, LE1
Zaia, AA1
Nakanjako, D1
Zalwango, F1
Wairagala, P1
Luboga, F1
Andia Biraro, I1
Bukirwa, VD1
Mboowa, MG1
Cose, S1
Seeley, J1
Elliott, A1
Zhao, G1
Sun, P1
Hao, S1
Wang, X2
Qu, G1
Xing, Y1
Xu, X1
Maierhofer, M1
Rieger, V1
Mayr, T1
Liu, Y2
Zhang, Q2
Bigliardi, AP1
Fernandes, CLF1
Pinto, EA1
Dos Santos, M1
Garcia, EM1
Baisch, PRM1
Soares, MCF1
Muccillo-Baisch, AL1
da Silva Júnior, FMR1
Yu, W1
Ju, C1
Wang, K1
Zheng, Z1
Liu, H1
Gao, Y1
Martínez-Navarro, EM1
Cebrián-Tarancón, C1
Moratalla-López, N1
Lorenzo, C1
Alonso, GL1
Salinas, RM1
Bermúdez de Castro, JM1
Modesto-Mata, M1
Martín-Francés, L1
García-Campos, C1
Martínez de Pinillos, M1
Martinón-Torres, M1
Hasani, M1
Wu, F2
Warriner, K1
Kurz, M1
Gretzke, D1
Hörlein, R1
Turpault, S1
Atzrodt, J1
Derdau, V1
Yao, Y1
Ou, X1
Zhao, S1
Tian, B1
Jin, S1
Jiang, Z1
Zhou, Z1
Liu, M2
Jiang, GD1
Mou, LH1
Chen, JJ1
Li, ZY1
He, SG1
Reale, E1
Fustinoni, S1
Mercadante, R1
Polledri, E1
Hopf, NB1
Grant, PC1
Levy, K1
Lattimer, TA1
Depner, RM1
Kerr, CW1
Sato, J1
Merenda, MEZ1
Uemoto, AT1
Dos Santos, MP1
Barion, MRL1
Carciofi, AC1
de Paula Dorigam, JC1
Ribeiro, LB1
Vasconcellos, RS1
Waller, SB1
Peter, CM1
Hoffmann, JF1
Cleff, MB1
Faria de, RO1
Zani, JL1
Martins, BA1
Sande, D1
Solares, MD1
Takahashi, JA1
Yang, S2
Jia, Y1
Yin, C1
Zhao, R1
Ojha, M1
Wu, B1
Deepa, M1
Mo, J1
Au, DW1
Wan, MT1
Shi, J1
Zhang, G1
Winkler, C1
Kong, RY1
Seemann, F1
Bianco, M1
Calvano, CD1
Ventura, G1
Bianco, G1
Losito, I1
Cataldi, TRI1
Angiolella, L1
Staudt, A1
Duarte, PF1
Amaral, BPD1
Peixoto Andrade, BCO1
Simas, NK1
Correa Ramos Leal, I1
Sangenito, LS1
Santos, ALSD1
de Oliveira, D1
Junges, A1
Cansian, RL1
Paroul, N1
Siu, J1
Klingler, L1
Hung, CT1
Jeong, SH1
Smith, S1
Tingle, MD1
Wagner Mackenzie, B1
Biswas, K1
Douglas, RG1
Oza, AM1
Lorusso, D1
Aghajanian, C1
Oaknin, A1
Dean, A1
Colombo, N1
Weberpals, JI1
Clamp, AR1
Scambia, G1
Leary, A1
Holloway, RW1
Gancedo, MA1
Fong, PC1
Goh, JC1
O'Malley, DM1
Armstrong, DK1
Banerjee, S1
García-Donas, J1
Swisher, EM1
Cella, D1
Meunier, J1
Goble, S1
Cameron, T1
Maloney, L1
Mörk, AC1
Bedel, J1
Ledermann, JA1
Coleman, RL1
Vlek, SL1
Burm, R1
Govers, TM1
Vleugels, MPH1
Tuynman, JB1
Mijatovic, V1
Leicht, AS1
Connor, J1
Conduit, N1
Vaquera, A1
Gómez, MA1
McKay, JA1
Church, AL1
Rubin, N1
Emory, TH1
Hoven, NF1
Kuehn-Hajder, JE1
Nelson, MT1
Ramanna, S1
Auerbach, EJ1
Moeller, S1
Bolan, PJ1
Fox, NP1
Leonard, M1
Sjerps, MJ1
Chang, EF1
Hyun, S1
Saejio, A1
Shanmugam, S1
Liu, X3
Sun, M1
Bai, Z1
Jaque-Fernandez, F1
Beaulant, A1
Berthier, C1
Monteiro, L1
Allard, B1
Casas, M1
Rieusset, J1
Jacquemond, V1
Góngora-García, OR1
Aca-Aca, G1
Baz-Rodríguez, SA1
Monte, A1
Maganaris, C1
Baltzopoulos, V1
Zamparo, P1
Wang, Z2
Hou, Y1
Cai, L1
Tu, YJ1
Tan, B1
Jiang, L1
Wu, ZH1
Yu, HJ1
Li, XQ1
Yang, AD1
Titze, IR1
Palaparthi, A1
Mau, T1
González, MA1
Goiri, F1
Barandika, JF1
García-Pérez, AL1
Jatt, LP1
Gandhi, MM1
Guo, R1
Sukhija-Cohen, A1
Bhattacharya, D1
Tseng, CH1
Chew, KW1
Onwumere, J1
Pia Tek, J1
Budnyak, T1
Budnyk, S1
Karim, Z1
Thersleff, T1
Kuśtrowski, P1
Mathew, AP1
Slabon, A1
Guo, M1
Zhao, T1
Xing, Z1
Qiu, Y1
Pan, K1
Li, Z2
Zhou, W1
Ghassemi Tabrizi, S1
Arbuznikov, AV1
Jiménez-Hoyos, CA1
Kaupp, M1
Lin, MH2
Bulman, DM1
Remucal, CK1
Chaplin, BP1
Laguerre, A1
George, LA1
Gall, ET1
Emerson, MS1
Wang, H3
Maginn, EJ1
Margulis, CJ1
Li, H2
Feng, W1
Kang, X2
Yan, S1
Chao, M1
Mo, S1
Sun, W1
Lu, Y1
Chen, C1
Stevens, DM1
Adiseshaiah, P1
Dasa, SSK1
Potter, TM1
Skoczen, SL1
Snapp, KS1
Cedrone, E1
Patel, N1
Busman-Sahay, K1
Rosen, EP1
Sykes, C1
Cottrell, M1
Dobrovolskaia, MA1
Estes, JD1
Kashuba, ADM1
Stern, ST1
Özütemiz, C1
Neil, EC1
Tanwar, M1
Rubin, NT1
Ozturk, K1
Cayci, Z1
Duscha, BD1
Kraus, WE1
Jones, WS1
Robbins, JL1
Piner, LW1
Huffman, KM1
Allen, JD1
Annex, BH1
Mehmood, T1
Ahmad, I1
Bibi, S1
Mustafa, B1
Ali, I1
Dahal, RH1
Chaudhary, DK1
Kim, DU1
Kim, J1
Yeter, HH1
Gonul, I1
Guz, G1
Helvaci, O1
Korucu, B1
Akcay, OF1
Derici, U1
Arinsoy, T1
Neffati, R1
Judeinstein, P1
Rault, J1
Xu, Y2
Chai, X1
Ren, T1
Yu, S1
Fu, Q2
Ye, J1
Ge, X1
Song, J1
Yang, H2
El-Baba, TJ1
Lutomski, CA1
Kantsadi, AL1
Malla, TR1
John, T1
Mikhailov, V1
Bolla, JR1
Schofield, CJ1
Zitzmann, N1
Vakonakis, I1
Robinson, CV1
Langham, MC1
Caporale, AS1
Wehrli, FW1
Parry, S1
Schwartz, N1
den Boer, RB1
Jones, KI1
Ash, S1
van Boxel, GI1
Gillies, RS1
O'Donnell, T1
Ruurda, JP1
Sgromo, B1
Silva, MA1
Maynard, ND1
Sivieri, EM1
Eichenwald, EC1
Rub, D1
Abbasi, S1
Krahnert, I1
Bolze, A1
Gibon, Y1
Fernie, AR1
Huang, L1
Wan, Y1
Dang, Z1
Yang, P1
Yang, Q1
Wu, S2
Lin, CC1
Hsu, CT1
Liu, W3
Huang, SC1
Kortz, U1
Mougharbel, AS1
Chen, TY1
Hu, CW1
Lee, JF1
Wang, CC1
Liao, YF1
Li, LJ1
Li, L1
Peng, S1
Stimming, U1
Hebbar Kannur, K1
Yaqub, TB1
Pupier, C1
Héau, C1
Cavaleiro, A1
Yamamoto, S1
Ono, A1
Matsui, J1
Hoshino, N1
Akutagawa, T1
Miyashita, T1
Mitsuishi, M1
Patel, SM1
Smith, TG1
Morton, M1
Stiers, KM1
Seravalli, J1
Mayclin, SJ1
Edwards, TE1
Tanner, JJ1
Becker, DF1
Butcher, TW1
Yang, JL1
Hartwig, JF1
Yu, MF1
Xia, ZZ1
Yao, JC1
Feng, Z1
Li, DH1
Liu, T1
Cheng, GJ1
He, DL1
Li, XH1
Huurman, R1
Schinkel, AFL1
de Jong, PL1
van Slegtenhorst, MA1
Hirsch, A1
Michels, M1
Kataja, A1
Tarvasmäki, T1
Lassus, J1
Sionis, A1
Mebazaa, A1
Pulkki, K1
Banaszewski, M1
Carubelli, V1
Hongisto, M1
Jankowska, E1
Jurkko, R1
Jäntti, T1
Kasztura, M1
Parissis, J1
Sabell, T1
Silva-Cardoso, J1
Spinar, J1
Tolppanen, H1
Harjola, VP1
Carsetti, A1
Damiani, E1
Casarotta, E1
Scorcella, C1
Domizi, R1
Gasparri, F1
Gabbanelli, V1
Pantanetti, S1
Carozza, R1
Adrario, E1
Donati, A1
Almada, E1
Pariani, A1
Rivabella Maknis, T1
Hidalgo, F1
Vena, R1
Favre, C1
Larocca, MC1
Lu, ZY1
Jiang, WD1
Wu, P1
Kuang, SY1
Tang, L1
Yang, J1
Zhou, XQ1
Feng, L1
Leal, M1
Zampini, IC1
Mercado, MI1
Moreno, MA1
Simirgiotis, MJ1
Bórquez, J1
Ponessa, G1
Isla, MI1
Saliu, IO1
Amoo, ZA1
Khan, MF1
Olaleye, MT1
Rema, V1
Akinmoladun, AC1
Khan, AU1
Rahman, AU1
Yuan, Q1
Ahmad, A1
Khan, ZUH1
Mahnashi, MH1
Alyami, BA1
Alqahtani, YS1
Ullah, S1
Wirman, AP1
Gao, M1
Deng, L1
Zhang, K1
Wang, M3
Xia, Z1
Gao, D2
Balkissou, AD1
Poka-Mayap, V1
Massongo, M1
Djenabou, A1
Endale-Mangamba, LM1
Olomo, EJ1
Boulleys-Nana, JR1
Diffo-Sonkoue, L1
Adidigue-Ndiome, R1
Alexandra, AJE1
Haman-Wabi, AB1
Adama, S1
Iddi-Faical, A1
Pefura-Yone, EW1
Zhao, Q1
Tong, W1
Ge, C1
Zhao, D1
Norbäck, D1
Li, B1
Zhao, Z1
Huang, C2
Zhang, X1
Qian, H1
Yang, X1
Sun, Y1
Sundell, J1
Deng, Q1
Kim, HJ2
Jeon, JW1
Hwang, SM1
Chu, KI1
Cha, YH1
Kwak, YD1
Choi, SD1
Aslam, M1
Kim, CG1
Zhou, J1
Yang, E1
Yang, W1
Amadou, A1
Praud, D1
Coudon, T1
Deygas, F1
Grassot, L1
Faure, E1
Couvidat, F1
Caudeville, J1
Bessagnet, B1
Salizzoni, P1
Gulliver, J1
Leffondré, K1
Severi, G1
Mancini, FR1
Fervers, B1
Shadboorestan, A1
Tarfiei, GA1
Montazeri, H1
Sepand, MR1
Zangooei, M1
Khedri, A1
Ostad, SN1
Ghahremani, MH1
Ma, Z1
Yu, Z1
Jaiswal, AS2
Panda, H1
Pampo, CA1
Siemann, DW1
Gairola, CG2
Hromas, R1
Narayan, S2
Pluchino, LA1
Wang, HC6
Guo, J1
Ji, W1
Song, L1
Dai, C1
Zhan, L1
Obinaju, BE1
Fullwood, NJ1
Kabil, A1
Silva, E1
Kortenkamp, A1
Song, X1
Siriwardhana, N1
Rathore, K4
Lin, D1
Choudhary, S2
Odoi, A1
Ronco, AL1
De Stefani, E1
Correa, P1
Deneo-Pellegrini, H1
Boffetta, P1
Acosta, G1
Mendilaharsu, M1
Kang, HJ1
Hong, YB1
Wang, A1
Bae, I1
Sood, S1
Bai, C1
Gao, H1
Ma, R1
Dong, Q1
Li, D4
Walcott, FL1
Chang, P2
Zhang, W1
Zhu, J1
Petrulis, E1
Singletary, SE1
Sahin, AA2
Bondy, ML2
Davis, C1
Bhana, S1
Shorrocks, AJ1
Kleiner, HE1
Reed, MJ1
DiGiovanni, J1
Kasili, PM1
Cullum, BM2
Griffin, GD2
Vo-Dinh, T2
BOCK, FG1
SMITH, DH1
DAO, TL1
Singletary, KW2
Barnes, SL1
van Breemen, RB1
Ueng, TH1
Wang, HW1
Huang, YP1
Hung, CC1
Plísková, M1
Vondrácek, J1
Vojtesek, B1
Kozubík, A1
Machala, M1
Mahadevan, B2
Keshava, C1
Musafia-Jeknic, T2
Pecaj, A1
Weston, A1
Baird, WM5
Calaf, GM2
Alvarado, ME4
Hei, TK2
Ramljak, D1
Romanczyk, LJ1
Metheny-Barlow, LJ1
Thompson, N1
Knezevic, V1
Galperin, M1
Ramesh, A1
Dickson, RB1
Miller, ME1
Holloway, AC1
Foster, WG1
Pereira, C1
Kang, SC1
Lee, BM1
Sparfel, L1
Van Grevenynghe, J1
Le Vee, M1
Aninat, C1
Fardel, O1
Hockings, JK1
Thorne, PA2
Kemp, MQ2
Morgan, SS1
Selmin, O3
Romagnolo, DF4
Bu, D1
Tomlinson, G1
Lewis, CM1
Zhang, C2
Kildebeck, E1
Euhus, DM1
Naftalis, E1
Euhus, D1
Kane, MD1
Kundu, CN1
Balusu, R1
Liu, S1
Abdelrahim, M1
Khan, S1
Ariazi, E1
Jordan, VC1
Safe, S3
Alexandrov, K1
Rojas, M1
Rolando, C1
Mello, ML4
Vidal, BC2
Russo, IH1
Lareef, MH2
Russo, J6
Jung, KJ1
Giusti, M1
Spink, DC2
Wu, SJ2
Spink, BC2
Hussain, MM2
Vakharia, DD1
Pentecost, BT1
Kaminsky, LS2
Sadikovic, B1
Andrews, J1
Carter, D1
Robinson, J1
Rodenhiser, DI1
Hewitt, R1
Forero, A1
Luncsford, PJ1
Tampio, M1
Loikkanen, J1
Myllynen, P1
Mertanen, A1
Vähäkangas, KH1
Hooven, LA1
Mason, ME1
Okey, AB1
Chagnaud, JL3
Amara, A1
Faiderbe, S3
Geffard, M3
Moore, M2
Lu, YF1
Wormke, M1
Craig, A1
Gerlach, JH1
Burghardt, R1
Barhoumi, R1
Calaf, G2
Tahin, Q1
Estrada, S1
Cox, T1
Dhingra, K2
Hittelman, WN2
Ruh, M1
Steinberg, M1
Liehr, JG1
de Andrade, M1
Telang, NT4
Katdare, M2
Bradlow, HL3
Osborne, MP4
Tannheimer, SL1
Barton, SL1
Ethier, SP1
Burchiel, SW1
Fishman, J1
Pfeifer, GP1
Denissenko, MF1
Jeffy, BD3
Schultz, EU1
Gudas, JM2
Bowden, GT1
Romagnolo, D1
Barbisan, LF1
Vidal, BD1
Miller, GH1
Garcia-Closas, M1
Rothman, N1
Lubin, J1
de Campos Vidal, B1
Charles, GD1
Bartels, MJ1
Zacharewski, TR2
Gollapudi, BB1
Freshour, NL1
Carney, EW1
Lightfoot, TJ1
Coxhead, JM1
Cupid, BC1
Nicholson, S1
Garner, RC1
Fertuck, KC1
Matthews, JB1
Kuljukka-Rabb, T1
Peltonen, K1
Isotalo, S1
Mikkonen, S1
Rantanen, L1
Savela, K1
Chirnomas, RB2
Chen, EJ1
Katz, BH1
Liu, N1
Pause, R1
Firozi, PF1
Lukmanji, F1
Singletary, ES1
Hassan, MM1
Hecht, SS1
Yeh, GC1
Lopaczynska, J1
Poore, CM1
Phang, JM1
Peryt, B1
Maurel, P1
Lesca, P1
Bourême, D1
Basu, A1
Modak, MJ1
Axelrod, DM1
Gould, MN1
Grau, DR1
Seidman, LA1
Moore, CJ1
Vickers, PJ1
Dufresne, MJ1
Cowan, KH2
Jaiswal, AK1
Gonzalez, FJ1
Nebert, DW2
Pruess-Schwartz, D1
Nikbakht, A1
Merrick, BA2
Selkirk, JK2
Ivy, SP1
Tulpule, A1
Fairchild, CR1
Averbuch, SD1
Myers, CE1
Mansfield, BK1
Nikbakht, PA1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Breath Test to Predict Breast Cancer and Outcome of Mammography[NCT04755829]1,000 participants (Anticipated)Observational2021-03-31Not yet recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

4 reviews available for benzo(a)pyrene and Breast Neoplasms

ArticleYear
    Zeitschrift fur Gesundheitswissenschaften = Journal of public health, 2022, Volume: 30, Issue:2

    Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain;

2022
Estradiol metabolism: an endocrine biomarker for modulation of human mammary carcinogenesis.
    Environmental health perspectives, 1997, Volume: 105 Suppl 3

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Anticarcinogenic Agents; Benzo(a)pyrene; Biomarkers; Breast; Breas

1997
Formation and repair of DNA lesions in the p53 gene: relation to cancer mutations?
    Environmental and molecular mutagenesis, 1998, Volume: 31, Issue:3

    Topics: 5-Methylcytosine; Animals; Benzo(a)pyrene; Breast Neoplasms; Carcinogens, Environmental; Colonic Neo

1998
Tobacco smoke carcinogens and breast cancer.
    Environmental and molecular mutagenesis, 2002, Volume: 39, Issue:2-3

    Topics: Animals; Benzo(a)pyrene; Breast Neoplasms; Carcinogens; Humans; Mutagens; Polycyclic Aromatic Hydroc

2002

Trials

1 trial available for benzo(a)pyrene and Breast Neoplasms

ArticleYear
    Zeitschrift fur Gesundheitswissenschaften = Journal of public health, 2022, Volume: 30, Issue:2

    Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain;

2022

Other Studies

87 other studies available for benzo(a)pyrene and Breast Neoplasms

ArticleYear
Whole transcriptome sequencing and competitive endogenous RNA regulation network construction analysis in benzo[a]pyrene-treated breast cancer cells.
    The Science of the total environment, 2023, Feb-25, Volume: 861

    Topics: Benzo(a)pyrene; Breast Neoplasms; Exome Sequencing; Female; Gene Regulatory Networks; Humans; MicroR

2023
Whole transcriptome sequencing and competitive endogenous RNA regulation network construction analysis in benzo[a]pyrene-treated breast cancer cells.
    The Science of the total environment, 2023, Feb-25, Volume: 861

    Topics: Benzo(a)pyrene; Breast Neoplasms; Exome Sequencing; Female; Gene Regulatory Networks; Humans; MicroR

2023
Whole transcriptome sequencing and competitive endogenous RNA regulation network construction analysis in benzo[a]pyrene-treated breast cancer cells.
    The Science of the total environment, 2023, Feb-25, Volume: 861

    Topics: Benzo(a)pyrene; Breast Neoplasms; Exome Sequencing; Female; Gene Regulatory Networks; Humans; MicroR

2023
Whole transcriptome sequencing and competitive endogenous RNA regulation network construction analysis in benzo[a]pyrene-treated breast cancer cells.
    The Science of the total environment, 2023, Feb-25, Volume: 861

    Topics: Benzo(a)pyrene; Breast Neoplasms; Exome Sequencing; Female; Gene Regulatory Networks; Humans; MicroR

2023
High-Resolution In Situ High-Content Imaging of 3D-Bioprinted Single Breast Cancer Spheroids for Advanced Quantification of Benzo(
    ACS applied materials & interfaces, 2023, Mar-08, Volume: 15, Issue:9

    Topics: Benzo(a)pyrene; Breast Neoplasms; Carcinogens; Cell Line, Tumor; Female; Humans; Neoplastic Stem Cel

2023
Parental occupational exposure to chemicals and risk of breast cancer in female offspring.
    Environmental research, 2023, 06-15, Volume: 227

    Topics: Benzo(a)pyrene; Breast Neoplasms; Case-Control Studies; Female; Humans; Male; Occupational Exposure;

2023
Interleukin-6 selectively induces drug metabolism to potentiate the genotoxicity of dietary carcinogens in mammary cells.
    Archives of toxicology, 2019, Volume: 93, Issue:10

    Topics: Benzo(a)pyrene; Breast Neoplasms; Carcinogens; Cell Line, Tumor; Cytochrome P-450 CYP1B1; DNA Damage

2019
Risk of breast cancer associated with long-term exposure to benzo[a]pyrene (BaP) air pollution: Evidence from the French E3N cohort study.
    Environment international, 2021, Volume: 149

    Topics: Air Pollution; Benzo(a)pyrene; Breast Neoplasms; Case-Control Studies; Cohort Studies; Female; Human

2021
Mechanistic evidence that benzo[a]pyrene promotes an inflammatory microenvironment that drives the metastatic potential of human mammary cells.
    Archives of toxicology, 2018, Volume: 92, Issue:10

    Topics: Benzo(a)pyrene; Breast Neoplasms; Carcinogens; Cyclooxygenase 2; Female; Gene Expression Regulation,

2018
Invasion and migration of MDA-MB-231 cells are inhibited by block of AhR and NFAT: role of AhR/NFAT1/β4 integrin signaling.
    Journal of applied toxicology : JAT, 2019, Volume: 39, Issue:2

    Topics: Benzo(a)pyrene; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Survival; Cyclosporine; Dose

2019
Carvedilol suppresses malignant proliferation of mammary epithelial cells through inhibition of the ROS‑mediated PI3K/AKT signaling pathway.
    Oncology reports, 2019, Volume: 41, Issue:2

    Topics: Antioxidants; Benzo(a)pyrene; Breast; Breast Neoplasms; Carvedilol; Cell Line; Cell Proliferation; C

2019
Adenomatous polyposis coli-mediated accumulation of abasic DNA lesions lead to cigarette smoke condensate-induced neoplastic transformation of normal breast epithelial cells.
    Neoplasia (New York, N.Y.), 2013, Volume: 15, Issue:4

    Topics: Adenomatous Polyposis Coli Protein; Animals; Apurinic Acid; Benzo(a)pyrene; Breast; Breast Neoplasms

2013
Chronic exposure to combined carcinogens enhances breast cell carcinogenesis with mesenchymal and stem-like cell properties.
    PloS one, 2014, Volume: 9, Issue:11

    Topics: Benzo(a)pyrene; Breast Neoplasms; Carcinogenesis; Carcinogens; DNA Damage; Drug Synergism; Epithelia

2014
Effects of exposure to benzo[a]pyrene on metastasis of breast cancer are mediated through ROS-ERK-MMP9 axis signaling.
    Toxicology letters, 2015, May-05, Volume: 234, Issue:3

    Topics: Animals; Benzo(a)pyrene; Breast Neoplasms; Carcinogens; Cell Movement; Female; Humans; Mammary Neopl

2015
Distinguishing nuclei-specific benzo[a]pyrene-induced effects from whole-cell alterations in MCF-7 cells using Fourier-transform infrared spectroscopy.
    Toxicology, 2015, Sep-01, Volume: 335

    Topics: Benzo(a)pyrene; Biomarkers; Breast Neoplasms; Cell Nucleus; DNA Damage; Female; Humans; MCF-7 Cells;

2015
Estrogens and genomic instability in human breast cancer cells--involvement of Src/Raf/Erk signaling in micronucleus formation by estrogenic chemicals.
    Carcinogenesis, 2008, Volume: 29, Issue:10

    Topics: Benzhydryl Compounds; Benzo(a)pyrene; Breast Neoplasms; Cell Line, Tumor; Estradiol; Estrogens; Extr

2008
Grape seed proanthocyanidin suppression of breast cell carcinogenesis induced by chronic exposure to combined 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and benzo[a]pyrene.
    Molecular carcinogenesis, 2010, Volume: 49, Issue:5

    Topics: Base Sequence; Benzo(a)pyrene; Blotting, Western; Breast Neoplasms; Carcinogens; Cell Adhesion; Cell

2010
Green tea catechin extract in intervention of chronic breast cell carcinogenesis induced by environmental carcinogens.
    Molecular carcinogenesis, 2012, Volume: 51, Issue:3

    Topics: Benzo(a)pyrene; Breast; Breast Neoplasms; Carcinogens, Environmental; Catechin; Cell Line; Cell Prol

2012
Green tea catechin intervention of reactive oxygen species-mediated ERK pathway activation and chronically induced breast cell carcinogenesis.
    Carcinogenesis, 2012, Volume: 33, Issue:1

    Topics: Benzo(a)pyrene; Breast Neoplasms; Catechin; Cell Proliferation; Cells, Cultured; DNA Damage; Extrace

2012
Dietary benzo[a]pyrene, alcohol drinking, and risk of breast cancer: a case-control study in Uruguay.
    Asian Pacific journal of cancer prevention : APJCP, 2011, Volume: 12, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Alcohol Drinking; Benzo(a)pyrene; Breast Neoplasms; Case-Control Stu

2011
Bioactive food components prevent carcinogenic stress via Nrf2 activation in BRCA1 deficient breast epithelial cells.
    Toxicology letters, 2012, Mar-07, Volume: 209, Issue:2

    Topics: Anticarcinogenic Agents; Benzo(a)pyrene; Blotting, Western; BRCA1 Protein; Breast Neoplasms; Cell Li

2012
Dipyridamole intervention of breast cell carcinogenesis.
    Molecular carcinogenesis, 2014, Volume: 53, Issue:3

    Topics: Apoptosis; Benzo(a)pyrene; Blotting, Western; Breast; Breast Neoplasms; Carcinogens; Cell Adhesion;

2014
Benzo[α]pyrene repressed DNA mismatch repair in human breast cancer cells.
    Toxicology, 2013, Feb-08, Volume: 304

    Topics: Benzo(a)pyrene; Blotting, Western; Breast Neoplasms; Carcinogens; Cell Line, Tumor; DNA Mismatch Rep

2013
Mesenchymal and stem-like cell properties targeted in suppression of chronically-induced breast cell carcinogenesis.
    Cancer letters, 2013, Jun-01, Volume: 333, Issue:1

    Topics: Benzo(a)pyrene; Breast Neoplasms; Catechin; Cell Transformation, Neoplastic; Epithelial-Mesenchymal

2013
Genetic and environmental determinants on tissue response to in vitro carcinogen exposure and risk of breast cancer.
    Cancer research, 2002, Aug-15, Volume: 62, Issue:16

    Topics: Adult; Aryl Hydrocarbon Hydroxylases; Benzo(a)pyrene; Breast Neoplasms; Case-Control Studies; Cocarc

2002
Oestrogens induce G(1) arrest in benzo[a]pyrene-treated MCF-7 breast cells whilst enhancing genotoxicity and clonogenic survival.
    Mutagenesis, 2002, Volume: 17, Issue:5

    Topics: Benzo(a)pyrene; Breast Neoplasms; Cell Division; Cell Survival; Colony-Forming Units Assay; DNA Dama

2002
Naturally occurring coumarins inhibit human cytochromes P450 and block benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene DNA adduct formation in MCF-7 cells.
    Chemical research in toxicology, 2003, Volume: 16, Issue:3

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Antineoplastic Agents; Benzo(a)pyrene; Breast Neoplasms; Carcinoge

2003
Nanosensor for in vivo measurement of the carcinogen benzo[a]pyrene in a single cell.
    Journal of nanoscience and nanotechnology, 2002, Volume: 2, Issue:6

    Topics: Antibodies; Benzo(a)pyrene; Biosensing Techniques; Breast Neoplasms; Carcinogens; Equipment Design;

2002
DEPOSITION OF BENZO(A)PYRENE IN MOUSE FAT AFTER ORAL ADMINISTRATION.
    Cancer research, 1964, Volume: 24

    Topics: Adipose Tissue; Administration, Oral; Animals; Benzo(a)pyrene; Benzopyrenes; Breast Neoplasms; Glyce

1964
Ethanol inhibits benzo[a]pyrene-DNA adduct removal and increases 8-oxo-deoxyguanosine formation in human mammary epithelial cells.
    Cancer letters, 2004, Jan-20, Volume: 203, Issue:2

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Acetaldehyde; Benzo(a)pyrene; Breast Neoplasms; Cell Line, Tumor; Deoxy

2004
Antiestrogenic effects of motorcycle exhaust particulate in MCF-7 human breast cancer cells and immature female rats.
    Archives of environmental contamination and toxicology, 2004, Volume: 46, Issue:4

    Topics: Air Pollutants; Animals; Benzo(a)pyrene; Benzoflavones; Binding, Competitive; Breast Neoplasms; Cell

2004
Deregulation of cell proliferation by polycyclic aromatic hydrocarbons in human breast carcinoma MCF-7 cells reflects both genotoxic and nongenotoxic events.
    Toxicological sciences : an official journal of the Society of Toxicology, 2005, Volume: 83, Issue:2

    Topics: Benz(a)Anthracenes; Benzo(a)pyrene; Benzothiazoles; Breast Neoplasms; Bromodeoxyuridine; Carcinogens

2005
Altered gene expression patterns in MCF-7 cells induced by the urban dust particulate complex mixture standard reference material 1649a.
    Cancer research, 2005, Feb-15, Volume: 65, Issue:4

    Topics: Apoptosis; Benzo(a)pyrene; Benzopyrenes; Biotransformation; Breast Neoplasms; Carcinogens; Cell Cycl

2005
Beta catenin is associated with breast cancer progression in vitro.
    International journal of oncology, 2005, Volume: 26, Issue:4

    Topics: Benzo(a)pyrene; beta Catenin; Breast Neoplasms; Cell Transformation, Neoplastic; Cytoskeletal Protei

2005
Pentameric procyanidin from Theobroma cacao selectively inhibits growth of human breast cancer cells.
    Molecular cancer therapeutics, 2005, Volume: 4, Issue:4

    Topics: Antioxidants; Benzo(a)pyrene; Biflavonoids; Breast; Breast Neoplasms; Catechin; Cell Line, Tumor; Ce

2005
Benzo-[a]-pyrene increases invasion in MDA-MB-231 breast cancer cells via increased COX-II expression and prostaglandin E2 (PGE2) output.
    Clinical & experimental metastasis, 2005, Volume: 22, Issue:2

    Topics: Benzo(a)pyrene; Blotting, Western; Breast Neoplasms; Carcinogens; Cyclooxygenase 2; Dinoprostone; Fe

2005
Oncoprotein expression and morphological phenotypes of human breast epithelial cells transformed by the c-Ha-ras oncogene.
    Oncology reports, 2005, Volume: 14, Issue:4

    Topics: Benzo(a)pyrene; Breast Neoplasms; Carcinogens; Cell Differentiation; Cell Line, Transformed; Cell Li

2005
Long-term effects of a standardized complex mixture of urban dust particulate on the metabolic activation of carcinogenic polycyclic aromatic hydrocarbons in human cells in culture.
    Toxicological sciences : an official journal of the Society of Toxicology, 2005, Volume: 88, Issue:2

    Topics: Aryl Hydrocarbon Hydroxylases; Benzo(a)pyrene; Benzopyrenes; Biotransformation; Breast Neoplasms; Ca

2005
Effect of estrogen receptor (ER) on benzo[a]pyrene-DNA adduct formation in human breast cancer cells.
    Journal of toxicology and environmental health. Part A, 2005, Nov-12, Volume: 68, Issue:21

    Topics: Benzo(a)pyrene; Breast Neoplasms; Cell Transformation, Neoplastic; DNA Adducts; Female; Humans; Rece

2005
Potent inhibition of carcinogen-bioactivating cytochrome P450 1B1 by the p53 inhibitor pifithrin alpha.
    Carcinogenesis, 2006, Volume: 27, Issue:3

    Topics: Apoptosis; Aryl Hydrocarbon Hydroxylases; Benzo(a)pyrene; Benzothiazoles; Breast Neoplasms; Carcinog

2006
The ligand status of the aromatic hydrocarbon receptor modulates transcriptional activation of BRCA-1 promoter by estrogen.
    Cancer research, 2006, Feb-15, Volume: 66, Issue:4

    Topics: Benzo(a)pyrene; BRCA1 Protein; Breast Neoplasms; Estradiol; Estrogen Receptor alpha; Gene Expression

2006
An intronic polymorphism associated with increased XRCC1 expression, reduced apoptosis and familial breast cancer.
    Breast cancer research and treatment, 2006, Volume: 99, Issue:3

    Topics: Adenine; Adult; Apoptosis; Base Sequence; Benzo(a)pyrene; Breast Neoplasms; Carcinogens; Case-Contro

2006
Carcinogen-induced DNA double strand break repair in sporadic breast cancer.
    The Journal of surgical research, 2006, Volume: 135, Issue:1

    Topics: Benzo(a)pyrene; Bleomycin; BRCA2 Protein; Breast Neoplasms; Carcinogens; Comet Assay; DNA; DNA Damag

2006
Induction of the transferrin receptor gene by benzo[a]pyrene in breast cancer MCF-7 cells: potential as a biomarker of PAH exposure.
    Environmental and molecular mutagenesis, 2006, Volume: 47, Issue:7

    Topics: Benzo(a)pyrene; Biomarkers, Tumor; Breast Neoplasms; Cell Line, Tumor; Female; Gene Expression Profi

2006
Cigarette smoke condensate-induced level of adenomatous polyposis coli blocks long-patch base excision repair in breast epithelial cells.
    Oncogene, 2007, Mar-01, Volume: 26, Issue:10

    Topics: Adenomatous Polyposis Coli Protein; Benzo(a)pyrene; Breast; Breast Neoplasms; Cell Line; Cell Line,

2007
Aryl hydrocarbon receptor agonists directly activate estrogen receptor alpha in MCF-7 breast cancer cells.
    Biological chemistry, 2006, Volume: 387, Issue:9

    Topics: Benzo(a)pyrene; Benzofurans; Binding Sites; Breast Neoplasms; Cell Line, Tumor; Cytochrome P-450 CYP

2006
DNA damage by benzo(a)pyrene in human cells is increased by cigarette smoke and decreased by a filter containing rosemary extract, which lowers free radicals.
    Cancer research, 2006, Dec-15, Volume: 66, Issue:24

    Topics: Benzo(a)pyrene; Breast Neoplasms; Cell Line, Tumor; DNA; DNA Damage; DNA, Neoplasm; Female; Filtrati

2006
DNA content and chromatin texture of human breast epithelial cells transformed with 17-beta-estradiol and the estrogen antagonist ICI 182,780 as assessed by image analysis.
    Mutation research, 2007, Apr-01, Volume: 617, Issue:1-2

    Topics: Benzo(a)pyrene; Breast; Breast Neoplasms; Cell Line, Transformed; Cell Nucleus; Cell Transformation,

2007
Anthocyanin-rich grape extract blocks breast cell DNA damage.
    Journal of medicinal food, 2007, Volume: 10, Issue:2

    Topics: Anthocyanins; Benzo(a)pyrene; Breast; Breast Neoplasms; Cell Division; Cell Line, Transformed; Cytoc

2007
Induction of CYP1A1 and CYP1B1 by benzo(k)fluoranthene and benzo(a)pyrene in T-47D human breast cancer cells: roles of PAH interactions and PAH metabolites.
    Toxicology and applied pharmacology, 2008, Feb-01, Volume: 226, Issue:3

    Topics: Aryl Hydrocarbon Hydroxylases; Benzo(a)pyrene; Biotransformation; Breast Neoplasms; Cell Line, Tumor

2008
Genome-wide H3K9 histone acetylation profiles are altered in benzopyrene-treated MCF7 breast cancer cells.
    The Journal of biological chemistry, 2008, Feb-15, Volume: 283, Issue:7

    Topics: Acetylation; Benzo(a)pyrene; Breast Neoplasms; Cell Line, Tumor; Chromatin Immunoprecipitation; Gene

2008
Enhanced micronucleus formation and modulation of BCL-2:BAX in MCF-7 cells after exposure to binary mixtures.
    Environmental health perspectives, 2007, Volume: 115 Suppl 1

    Topics: bcl-2-Associated X Protein; Benzo(a)pyrene; Breast Neoplasms; Cell Line, Tumor; Cyclin-Dependent Kin

2007
Benzo(a)pyrene increases phosphorylation of p53 at serine 392 in relation to p53 induction and cell death in MCF-7 cells.
    Toxicology letters, 2008, May-30, Volume: 178, Issue:3

    Topics: Adenocarcinoma; Apoptosis; Benzo(a)pyrene; Breast Neoplasms; Carcinogens; Cell Line, Tumor; Cell Pro

2008
Proteomic analysis of MCF-7 cells treated with benzo[a]pyrene, dibenzo[a,l]pyrene, coal tar extract, and diesel exhaust extract.
    Toxicology, 2008, Jul-10, Volume: 249, Issue:1

    Topics: Benzo(a)pyrene; Benzopyrenes; Breast Neoplasms; Carcinogens; Cell Line, Tumor; Coal Tar; Electrophor

2008
Aryl hydrocarbon hydroxylase activity in mouse, rat, and human mammary tumors.
    Cancer research, 1981, Volume: 41, Issue:7

    Topics: Animals; Aryl Hydrocarbon Hydroxylases; Benzo(a)pyrene; Benzoflavones; Benzopyrenes; beta-Naphthofla

1981
Identification of a benzo[a]pyrene-like binding protein involved in circulating immune complexes of patients with mammary tumors.
    Cancer letters, 1995, May-08, Volume: 91, Issue:2

    Topics: Antigen-Antibody Complex; Autoantibodies; Benzo(a)pyrene; Breast Neoplasms; Carrier Proteins; Humans

1995
Benzo[a]pyrene-resistant MCF-7 human breast cancer cells. A unique aryl hydrocarbon-nonresponsive clone.
    The Journal of biological chemistry, 1994, Apr-22, Volume: 269, Issue:16

    Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Base Sequence; Benzo(a)pyrene; Breast Neopl

1994
Hormone receptors and cathepsin D levels in human breast epithelial cells transformed by chemical carcinogens and c-Ha-ras transfection.
    Breast cancer research and treatment, 1994, Volume: 29, Issue:2

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Benzo(a)pyrene; Breast; Breast Neoplasms; Cathepsin D; Ce

1994
Aromatic DNA adducts in adjacent tissues of breast cancer patients: clues to breast cancer etiology.
    Cancer research, 1996, Jan-15, Volume: 56, Issue:2

    Topics: Adult; Age Factors; Aged; Aged, 80 and over; Benzo(a)pyrene; Breast; Breast Neoplasms; Carcinogens;

1996
Isolation and characterization of variant benzo[a]pyrene-resistant T47D human breast-cancer cells.
    International journal of cancer, 1996, Mar-28, Volume: 66, Issue:1

    Topics: Base Sequence; Benzo(a)pyrene; Breast Neoplasms; Cell Division; Cytochrome P-450 Enzyme System; DNA

1996
Lipid peroxidation-induced putative malondialdehyde-DNA adducts in human breast tissues.
    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 1996, Volume: 5, Issue:9

    Topics: Adult; Age Factors; Aged; Aged, 80 and over; Benzo(a)pyrene; Biomarkers, Tumor; Body Mass Index; Bre

1996
Carcinogenic polycyclic aromatic hydrocarbons increase intracellular Ca2+ and cell proliferation in primary human mammary epithelial cells.
    Carcinogenesis, 1997, Volume: 18, Issue:6

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Benzo(a)pyrene; Benzoflavones; Breast; Breast Neoplasms; Calcium;

1997
Inhibition of proliferation and modulation of estradiol metabolism: novel mechanisms for breast cancer prevention by the phytochemical indole-3-carbinol.
    Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1997, Volume: 216, Issue:2

    Topics: Anticarcinogenic Agents; Apoptosis; Benzo(a)pyrene; Breast; Breast Neoplasms; Carcinogens; Cell Divi

1997
Inhibition of BRCA-1 expression by benzo[a]pyrene and its diol epoxide.
    Molecular carcinogenesis, 1999, Volume: 26, Issue:2

    Topics: 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide; Benzo(a)pyrene; Blotting, Western; Breast Neopla

1999
RNA relocation at mitosis in transformed and tumorigenic human breast epithelial cells.
    Cell biology international, 1999, Volume: 23, Issue:2

    Topics: Benzo(a)pyrene; Biological Transport, Active; Breast Neoplasms; Cell Line, Transformed; Cell Nucleol

1999
Intracellular measurements in mammary carcinoma cells using fiber-optic nanosensors.
    Analytical biochemistry, 2000, Jan-01, Volume: 277, Issue:1

    Topics: Animals; Benzo(a)pyrene; Biosensing Techniques; Breast Neoplasms; Cell Line; Epithelial Cells; Femal

2000
Misclassification in case-control studies of gene-environment interactions: assessment of bias and sample size.
    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 1999, Volume: 8, Issue:12

    Topics: Benzo(a)pyrene; Bias; Body Mass Index; Breast Neoplasms; Case-Control Studies; Cocarcinogenesis; Eff

1999
Ha-ras oncogene effect on DNA content and chromatin supraorganization in benzo[a]pyrene-transformed human breast epithelial cells.
    Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology, 1999, Volume: 19, Issue:2

    Topics: Benzo(a)pyrene; Breast Neoplasms; Cell Line, Transformed; Chromatin; Coloring Agents; DNA, Neoplasm;

1999
Activity of benzo[a]pyrene and its hydroxylated metabolites in an estrogen receptor-alpha reporter gene assay.
    Toxicological sciences : an official journal of the Society of Toxicology, 2000, Volume: 55, Issue:2

    Topics: Benzo(a)pyrene; Benzoflavones; beta-Galactosidase; Breast Neoplasms; Chromatography, High Pressure L

2000
Analysis of DNA adducts by accelerator mass spectrometry in human breast tissue after administration of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and benzo[a]pyrene.
    Mutation research, 2000, Dec-20, Volume: 472, Issue:1-2

    Topics: Aged; Benzo(a)pyrene; Biological Availability; Biotransformation; Breast; Breast Neoplasms; Carbon R

2000
Hydroxylated benzo[a]pyrene metabolites are responsible for in vitro estrogen receptor-mediated gene expression induced by benzo[a]pyrene, but do not elicit uterotrophic effects in vivo.
    Toxicological sciences : an official journal of the Society of Toxicology, 2001, Volume: 59, Issue:2

    Topics: Animals; Benzo(a)pyrene; Breast Neoplasms; DNA Primers; Dose-Response Relationship, Drug; Estradiol;

2001
Morphological phenotypes in neoplastic progression of benz(alpha)pyrene-treated breast epithelial cells.
    Journal of submicroscopic cytology and pathology, 2000, Volume: 32, Issue:4

    Topics: Animals; Benzo(a)pyrene; Breast; Breast Neoplasms; Carcinogens; Cell Line; Cell Transformation, Neop

2000
Time- and dose-dependent DNA binding of PAHs derived from diesel particle extracts, benzo[a]pyrene and 5-methychrysene in a human mammary carcinoma cell line (MCF-7).
    Mutagenesis, 2001, Volume: 16, Issue:4

    Topics: Benzo(a)pyrene; Breast Neoplasms; Carcinogenicity Tests; Carcinogens; Chrysenes; DNA Adducts; DNA, N

2001
Activation of the aromatic hydrocarbon receptor pathway is not sufficient for transcriptional repression of BRCA-1: requirements for metabolism of benzo[a]pyrene to 7r,8t-dihydroxy-9t,10-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene.
    Cancer research, 2002, Jan-01, Volume: 62, Issue:1

    Topics: 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide; Benzo(a)pyrene; Biotransformation; BRCA1 Protein

2002
Induction of CYP1A1 and CYP1B1 in T-47D human breast cancer cells by benzo[a]pyrene is diminished by arsenite.
    Drug metabolism and disposition: the biological fate of chemicals, 2002, Volume: 30, Issue:3

    Topics: Arsenites; Aryl Hydrocarbon Hydroxylases; Benzo(a)pyrene; Blotting, Western; Breast Neoplasms; Chrom

2002
Aromatic DNA adducts and polymorphisms of CYP1A1, NAT2, and GSTM1 in breast cancer.
    Carcinogenesis, 2002, Volume: 23, Issue:2

    Topics: Adult; Age Factors; Aged; Aged, 80 and over; Arylamine N-Acetyltransferase; Benzo(a)pyrene; Breast;

2002
Epigenetics of breast cancer: polycyclic aromatic hydrocarbons as risk factors.
    Environmental and molecular mutagenesis, 2002, Volume: 39, Issue:2-3

    Topics: 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide; Benzo(a)pyrene; Benzoflavones; Blotting, Western

2002
RNA relocation and persistence of nucleolus-like bodies at mitosis in benzo[a]pyrene-transformed human breast epithelial cells after microcell-mediated transfer of chromosomes 11 and 17.
    Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology, 2001, Volume: 23, Issue:3-4

    Topics: Benzo(a)pyrene; Breast Neoplasms; Carcinoma; Cell Line, Transformed; Cell Nucleolus; Chromosomes, Hu

2001
A new functional role for P-glycoprotein: efflux pump for benzo(alpha)pyrene in human breast cancer MCF-7 cells.
    Cancer research, 1992, Dec-01, Volume: 52, Issue:23

    Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzo(a)pyrene; Breast Neoplasms; Doxorubic

1992
Characterization of the 4 S polycyclic aromatic hydrocarbon-binding protein in human liver and cells.
    Archives of biochemistry and biophysics, 1992, Nov-01, Volume: 298, Issue:2

    Topics: Animals; Benzo(a)pyrene; Binding Sites; Breast Neoplasms; Carrier Proteins; Cell Fractionation; Cell

1992
Identification and immunochemical characterization of IgA in sera of patients with mammary tumors.
    International journal of cancer, 1992, Feb-01, Volume: 50, Issue:3

    Topics: Age Factors; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal; Antibody Affinity; Antibody Specifi

1992
Visualization of a protein involved in seric immune complexes of patients with epithelial tumors having elevated levels of anti-'benzo[a]pyrene-like' IgA.
    Cancer letters, 1991, Dec-01, Volume: 60, Issue:3

    Topics: Antibodies, Monoclonal; Antigen-Antibody Complex; Autoantibodies; Benzo(a)pyrene; Biomarkers, Tumor;

1991
Cellular ras protooncogene expression in human mammary explant cultures. A potential marker for chemical carcinogenesis.
    Annals of the New York Academy of Sciences, 1990, Volume: 586

    Topics: Adult; Benzo(a)pyrene; Biomarkers, Tumor; Breast; Breast Neoplasms; Cell Transformation, Neoplastic;

1990
Metabolic biotransformation of estradiol in human mammary explant cultures.
    Annals of the New York Academy of Sciences, 1990, Volume: 586

    Topics: Adult; Aryl Hydrocarbon Hydroxylases; Benzo(a)pyrene; Biomarkers, Tumor; Breast; Breast Neoplasms; C

1990
Interspecies comparison of human and rat mammary epithelial cell-mediated mutagenesis by polycyclic aromatic hydrocarbons.
    Cancer research, 1986, Volume: 46, Issue:10

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Benzo(a)pyrene; Biotransformation; Breast; Breast Neoplas

1986
Relation between cytochrome P450IA1 expression and estrogen receptor content of human breast cancer cells.
    Molecular endocrinology (Baltimore, Md.), 1989, Volume: 3, Issue:1

    Topics: Aryl Hydrocarbon Hydroxylases; Benzo(a)pyrene; Breast Neoplasms; Cell Nucleus; Cytochrome P-450 Enzy

1989
Human P1-450 gene sequence and correlation of mRNA with genetic differences in benzo[a]pyrene metabolism.
    Nucleic acids research, 1985, Jun-25, Volume: 13, Issue:12

    Topics: Base Composition; Base Sequence; Benzo(a)pyrene; Breast Neoplasms; Cell Line; Cells, Cultured; Cytoc

1985
Benzo(a)pyrene:DNA adduct formation in normal human mammary epithelial cell cultures and the human mammary carcinoma T47D cell line.
    Cancer research, 1986, Volume: 46, Issue:6

    Topics: 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide; Benzo(a)pyrene; Benzopyrenes; Breast; Breast Neo

1986
Altered regulation of P-450IA1 expression in a multidrug-resistant MCF-7 human breast cancer cell line.
    The Journal of biological chemistry, 1988, Dec-15, Volume: 263, Issue:35

    Topics: Aryl Hydrocarbon Hydroxylases; Benzo(a)pyrene; Blotting, Northern; Breast Neoplasms; Cell Line; Chlo

1988
Benzo[a]pyrene metabolism in human T 47D mammary tumor cells: evidence for sulfate conjugation and translocation of reactive metabolites across cell membranes.
    Cancer letters, 1985, Volume: 29, Issue:2

    Topics: Benzo(a)pyrene; Breast Neoplasms; Cell Line; Cell Membrane; Cells, Cultured; Chromatography, High Pr

1985